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Results: Irradiation with low doses enhanced the motility of 
the cells. Slit2 as well as Robo1 was extremely low expressed 
in the cell line with higher motility (U87). Irradiation reduced 
the expression even more. On the other hand, a stable 
overexpression of Robo1 decreased significantly the migration 
of the cells and suppressed the increase in motility observed 
after irradiation. In contrast, the siRNA mediated knockdown 
of Robo1 increased the migratory potential of the cells. The 
analysis of FAK, a key player in cellular migration, revealed a 
decreased expression in Robo1-overexpressing cells. 
 
Conclusion: Our data indicate a role for Robo1 in the 
migration of malignant GBM cells. The expression of Robo1 
reduced the migration of these cells and was also able to 
impede the increase in motility observed after irradiation 
with photons. 
 
Poster: Radiobiology track: Radiobiology of protons and 
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Purpose or Objective: Proton minibeam radiotherapy aims to 
minimize normal tissue damage in the entrance channel 
while keeping tumor control through a homogeneous tumor 
dose due to channel widening with increasing track length. 
Side effects of proton minibeam irradiation were examined in 
an in-vivo mouse model to account for immune system, 
vasculature and higher complexity. Here, we report on our 
comparative study of minibeam and broad beam irradiation in 
the ear of Balb/c mice, to prove this hypothesis of reduced 
adverse effects in normal tissue. 
 
Material and Methods: At the ion microprobe SNAKE, 20 MeV 
protons were administered to the right ear of 2-3 months old, 
female Balb/c mice, using an average dose of 60 Gy in a field 
of 7.2 x 7.2 mm2 in the central part of the ear, in two 
irradiation modes, homogeneous and minibeams. The 4 x 4 
minibeams of 180 x 180 µm2 size were set in a distance of 1.8 
mm, resulting in a dose of 6000 Gy in the channels, but with 
negligible dose in between. Inflammatory response, i.e. ear 
swelling and skin reactions were monitored for 90 days 
following irradiation, as well as genetic damage and release 
of inflammatory proteins. 
 
Results: No ear swelling or other skin reaction was detected 
after the minibeam irradiations, while significant ear swelling 
(up to 4-fold), erythema and desquamation (crust formation) 
developed in homogeneously irradiated ears 3-4 weeks after 
irradiation. Loss of hair follicles was only detected in the 
homogeneously irradiated fields after 4-5 weeks. 
 
Conclusion: Our results prove that proton minibeam 
radiotherapy leads to reduced side effects compared to 
conventional broad beam irradiation and could become an 
option in clinical proton and/or heavy ion therapy.  
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Purpose or Objective: Metastasis is an important cause of 
mortality in cancer patients and evidence shows that 
irradiation could actually increase the formation of 
metastasizing cells. An important pathway implicated in the 
process of metastasis is the Hedgehog (Hh) signaling 
pathway. Recent studies demonstrated that activation of this 
pathway can lead to radioresistance. So far, the impact of 
high-LET radiation on the Hh pathway is still unknown. In the 
present study the impact of different radiation qualities (e.g. 
X-rays and carbon ions) on Hh gene expression was 
investigated in prostate cancer cells (PC3) and 
medulloblastoma cells (DAOY). 
 
Material and Methods: In vitro models used for prostate 
cancer and medulloblastoma were PC3 and DAOY, 
respectively. Colony survival assays were performed to 
analyze the effect of radiation on cell survival. The impact of 
radiation on the expression of the different Hh signaling 
pathway components (SHH, PTCH, SMO, GLI1, GLI2, GLI3 and 
SUFU) was investigated by means of RT-qPCR. Experiments 
with X-rays were performed at SCK•CEN (Mol, Belgium) 
whereas carbon ion irradiation (LET = 33.7 KeV/µm) 
experiments were performed at the Grand Accélérateur 
National d’Ions Lourds (GANIL) (Caen, France).  
 
Results: Colony survival assays showed that DAOY cells were 
more radioresistant than PC3 cells (respectively D10=5.3 Gy 
and D10=4.2 Gy). Evaluation of the Hh signaling pathway 
showed that basal gene expression is present in both PC3 and 
DAOY, although very low. However, basal gene expression of 
the Hh components differed between both cell lines. 
Moreover, the more radioresistant cell line DAOY had higher 
expression levels of Gli1 compared to the PC3 cells. 
Preliminary RT-qPCR results show that different radiation 
qualities induce different changes in the expression of the Hh 
signaling components. 
 
Conclusion: In conclusion, radiation exposure can induce 
changes in the Hh pathway. Future experiments will address 
whether modulation of the Hh pathway also affects the radio-
responsiveness of cancer cells. 
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Purpose or Objective: This retrospective study aimed to 
compare and determine the potential dosimetric benefits of 
intensity-modulated radiotherapy (IMRT) treatment plans 
with (FF) and without flattening filter (FFF) as well as to 
explore the dosimetric differences in 6MV FFF and 10MV FFF 
plans for non-small-cell lung carcinoma (NSCLC). 
 
Material and Methods: Ten cases of CT data were selected 
from NSCLC patients. 4 sets of 5-field-IMRT plans were 
computed with FFF beams (X6FFF, X10FFF) and flattened 
beams (X6FF, X10FF) with the prescription of total 60Gy in 30 
fractions. Planning constraints were based on the Radiation 
